Immunome Inc.

Ownership Transactions Reported by 26 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	3	+314 K	100%	$8.50	+$2.67 M
Sells	0
Net	+3	+314 K	100%		+$2.67 M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Isaac Barchas	Director	$16.7 M			Jun 13, 2024
Michael Rapp	Director	$7.56 M			Oct 2, 2023
Clay B. Siegall	President and CEO, Director	$5.78 M	+$2.39 M	+70.4%	May 20, 2024
Franklyn G. Prendergast	Director	$360 K			Oct 2, 2023
Bruce Turner	Chief Strategy Officer	$250 K	+$250 K		Oct 2, 2023
Jean Jacques Bienaime	Director	$130 K	+$27.1 K	+26.3%	Jun 13, 2024
Max Rosett	EVP, Operations & CFO	$117 K			May 16, 2024
Bob Lapetina	PAO and VP Finance & Corporate	$71.2 K			Jan 2, 2024
Sandra Stoneman	Chief Legal Officer & Gc				Jan 31, 2024
Matthew K. Robinson	Chief Technology Officer				Jun 8, 2023
James P. Boylan	Director				Jun 13, 2024
John L. Lamattina	Director				Jun 8, 2023
Richard A. Baron	Director				Jun 8, 2023
Carol Schafer	Director				Jun 13, 2024
Philip Wagenheim	Director				Jun 13, 2024
Philip Tsai	Chief Technology Officer				Jun 17, 2024
Jack Higgins	Chief Scientific Officer				Dec 1, 2023
Robert Lechleider	Chief Medical Officer				Oct 27, 2023
Phil Noland Roberts	Chief Technology Officer				Dec 13, 2023
Sandra M. Swain	Director				Jun 13, 2024
Michael Lefenfeld	Director				Jun 8, 2023
Dennis H. Giesing	Chief Development Officer				Jun 8, 2023
Michael Widlitz	Director				May 28, 2021
Purnanand D. Sarma	President and CEO, Director				Jun 8, 2023
Kinney Horn	Chief Business Officer				Feb 20, 2024
Corleen Roche	Chief Financial Officer				Jun 8, 2023

Insider	Class	Transaction	%	Value $	Price $	Shares	Shares Owned	Date	Ownership